Endo Acquires Rights to Trimel’s Natesto Testosterone Nasal Gel
News
Endo International has announced it acquired the rights to Natesto, a testosterone nasal gel that acts as replacement therapy in men diagnosed with hypogonadism, from Trimel BioPharma SRL. Natesto, approved by ... Read more